ConductScience.org, home

Paper17877427

Characterization of the theorectical radiation dose enhancement from nanoparticles.

Roeske JC and 4 others. Technol Cancer Res Treat, 2007. Cited by 102 papers, by iCite.

Cite this record

ConductScience Library. Characterization of the theorectical radiation dose enhancement from nanoparticles. Papers, record 17877427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17877427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of the theorectical radiation dose enhancement from nanoparticles.
PubMed
Journal
Technol Cancer Res Treat
PubMed
Year
2007
PubMed
Publication types
Evaluation Study, Journal Article
PubMed
Citations, by iCite
102
iCite
Relative citation ratio, by iCite
2.68
iCite
Revised in PubMed
2022-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roeske JCJohn C
2Nunez LLuis
3Hoggarth MMark
4Labay EEdwardine
5Weichselbaum RRRalph R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanoparticlesMajor topic
NeoplasmsMajor topic
Radiation DosageMajor topic
RadioisotopesMajor topic
Animals
Brachytherapy
Dose-Response Relationship, Radiation
Humans
Models, Theoretical
Radiotherapy Dosage

Source PubMed

Download CSV of topics

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.

PMIDTitleJournalYearIn PapersSource
42794870The Impact of Nanoparticles on Proton Therapy: A Review Study.Cancers (Basel)2026https://conductscience.org/library/papers/42794870PubMed
41899847Simulation-Based X-Ray Spectrum Optimization for Dose Enhancement in X-Ray-Induced Photodynamic Therapy with NaLuF4:20% Gd, 15% Tb3+ Nanocrystals.Bioengineering (Basel)2026https://conductscience.org/library/papers/41899847PubMed
41684504Dose Enhancement Due to Various Nanoparticles Irradiated by Megavoltage Photon Beams: A Review Study.J Med Phys2025https://conductscience.org/library/papers/41684504PubMed
41304042Poly(glycerol)-Functionalized Gadolinium Tungstate Nanoflakes Loaded with Chlorin e6: Photodynamic Efficacy and Radiosensitization Potential for Multimodal Cancer Therapy.Materials (Basel)2025https://conductscience.org/library/papers/41304042PubMed
40959486Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models.Nanotheranostics2025https://conductscience.org/library/papers/40959486PubMed
40213580Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models.Small Sci2024https://conductscience.org/library/papers/40213580PubMed
38935922Nanoscale gold nanoparticle (GNP)-laden tumor cell model and its use for estimation of intracellular dose from GNP-induced secondary electrons.Med Phys2024https://conductscience.org/library/papers/38935922PubMed
38703297Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.EJNMMI Radiopharm Chem2024https://conductscience.org/library/papers/38703297PubMed
38449099The Effect of Dose Enhancement in Tumor With Silver Nanoparticles on Surrounding Healthy Tissues: A Monte Carlo Study.Technol Cancer Res Treat2024https://conductscience.org/library/papers/38449099PubMed
38063741Monitoring Tools and Strategies for Effective Electrokinetic Nanoparticle Treatment.Nanomaterials (Basel)2023https://conductscience.org/library/papers/38063741PubMed
37947718Inorganic Nanoparticles as Radiosensitizers for Cancer Treatment.Nanomaterials (Basel)2023https://conductscience.org/library/papers/37947718PubMed
37555747Prospects of nanoparticle-based radioenhancement for radiotherapy.Mater Horiz2023https://conductscience.org/library/papers/37555747PubMed
37374815Depth Dose Enhancement in Orthovoltage Nanoparticle-Enhanced Radiotherapy: A Monte Carlo Phantom Study.Micromachines (Basel)2023https://conductscience.org/library/papers/37374815PubMed
36980778The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment.Cancers (Basel)2023https://conductscience.org/library/papers/36980778PubMed
36873996Nanoparticle-based radiosensitization strategies for improving radiation therapy.Front Pharmacol2023https://conductscience.org/library/papers/36873996PubMed
36081572Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy.Int J Nanomedicine2022https://conductscience.org/library/papers/36081572PubMed
35668122Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy.Nat Commun2022https://conductscience.org/library/papers/35668122PubMed
35454910Deep-Tissue Activation of Photonanomedicines: An Update and Clinical Perspectives.Cancers (Basel)2022https://conductscience.org/library/papers/35454910PubMed
35261497Use of Poly (Ethylene Glycol) Coated Superparamagnetic Iron Oxide Nanoparticles as Radio Sensitizer in Enhancing Colorectal Cancer Radiation Efficacy.J Med Phys2021https://conductscience.org/library/papers/35261497PubMed
35053455ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma.Cancers (Basel)2022https://conductscience.org/library/papers/35053455PubMed

See all 56 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17877427

GET https://conductscience.org/api/papers/v1/17877427/cited_by?page=2